Infertility affects 10-15% of couples, and approximately 50% of cases are linked to male factor infertility. The purpose of this study was to evaluate the DNA methylation patterns in spermatozoa from males who are suffering from a reduction in fecundity. Thirty samples were subjected to 450K arrays as a screening study to evaluate the variation in sperm DNA methylation levels between cases and controls groups, and then four CpG sites (cg05799088, cg07227024, cg16338278, and cg08408433) underwent to deep bisulfite sequencing to validate the observed methylation differences in 111 samples (56 proven fertile males as 'controls' and 55 males suffering from a reduction in fecundity as 'cases'). A significant difference in the mean methylation level was found between cases and controls in the CpGs of PRICKLE2 gene-related amplicon (CpG1, p ≤ 0.002, and CpG2, p ≤ 0.004) and CpG of ALS2CR12 gene-related amplicon (CpG1, p ≤ 0.015, and CpG2, p ≤ 0.009). Besides, a significant difference was found at seven from thirteen CpGs tested in the ALDH3B2 gene amplicon CpG2, CpG6, CpG9, CpG10, CpG11, CpG12, and CpG13 (p ≤ 0.005, p ≤ 0.004, p ≤ 0.012, p ≤ 0.028, p ≤ 0.012, p ≤ 0.009, and p ≤ 0.001, respectively). In addition, the results showed that nine CpGs out of the twenty-six within the PTGIR gene-related amplicon (CpG4, CpG6, CpG8, CpG9, CpG11, CpG15, CpG19, CpG23, and CpG26) had a significant difference in their mean methylation level (p ≤ 0.006, p ≤ 0.009, p ≤ 0.003, p ≤ 0.003, p ≤ 0.007, p ≤ 0.002, p ≤ 0.018, p ≤ 0.018, and p ≤ 0.040, respectively) in the case vs. control group. In conclusion, an alteration in the methylation levels of sperm DNA from males with reduced fecundity was observed. In addition, an association between changes in the methylation level for these CpGs and different semen parameters has been found.
INTRODUCTION
Infertility affects 10-15% of couples, and approximately 50% of cases are linked to male factor infertility (Nieschlag et al., 2011; Mascarenhas et al., 2012; Raheem et al., 2012; Inhorn & Patrizio, 2015; Kumar & Singh, 2015) . In recent decades, many studies have found that approximately 60% of infertility cases are classified as unexplained infertility (Erenpreiss et al., 2006; Anawalt, 2013; Yassin et al., 2017) . Besides genetic causes, aberrant patterns of DNA methylation and histone modification have been shown to play a role in male infertility or fecundity decline, and have been identified in 15-30% of infertile males (Amor & Halliday, 2008; Pliushch et al., 2010; Esteves, 2013; Soubry, 2015; Jenkins et al., 2016a) . The molecular mechanisms of these defects need more clarification and explanation since male infertility has been clarified as a phenotype of the deficiency in the transcription of various single genes (Matzuk & Lamb, 2002) .
DNA methylation is an epigenetic mechanism used by cells to regulate gene expression, and which occurs by the addition of a methyl (CH3) group to fifth carbon atom of cytosine (Sch€ ubeler, 2015) . DNA methylation plays a critical role in the regulation of gene transcription during sperm development (Portela & Esteller, 2010; Ankolkar et al., 2012; Hackett & Surani, 2013) . In human, DNA methyltransferases (DNMTs) are responsible for the transfer of a methyl group (CH3) to 5-cytosine of CpG dinucleotides to form 5-methylcytosine (Smith & Meissner, 2013; Celik et al., 2016) . The methylated state of CpGs has a critical impact on gene transcription during embryonic growth, genomic imprinting, X-chromosome inactivation, and tumor development (Chalign e & Heard, 2014; Liyanage et al., 2014; Heyn et al., 2016) based on CpG islands found in the 5 0 regulatory and promoter regions of genes. Recent findings have shown that epigenetic regulation plays a crucial role in neurodevelopment, aging, and many human diseases (Tan & Shi, 2012; Kaas et al., 2013; Feinberg et al., 2015; Jones et al., 2015) . Several studies have illustrated that changes in the DNA methylation of specific genes in germ cells are linked with oligozoospermia, reduced progressive sperm motility, and abnormal sperm morphology (Marques et al., 2008; Hammoud et al., 2010) . Likewise, a recent study detected aberrant DNA methylation levels for genes involved in the spermatogenic program and located outside of imprinted regions in poor quality spermatozoa (Navarro-Costa et al., 2010) . Aberrant sperm DNA methylation is one of the most relevant aspects of epigenetic abnormalities in spermatozoa; these defects can be transmitted to children and can affect the child's susceptibility to disease (Wei et al., 2014) . However, in a number of cases, the cause of infertility is still unknown because of a lack of knowledge of the genetic and molecular mechanisms that play a role in the control of sperm cell production and maturation. Therefore, the discovery of new genes that may participate in spermatogenesis and studying their functions and methylation status may help to understand fertility problems in males.
The purpose of this study was (i) related to determine whether sperm DNA methylation at CpG dinucleotides is different in males suffering from a reduction in fecundity compared to proven fertile males, and (ii) to assess the relationship between changes in sperm DNA methylation levels, especially in the PRICKLE2, ALS2CR12, ALDH3B2, and PTGIR genes, and abnormalities in semen parameters.
MATERIALS AND METHODS

Patient recruitment and spermatozoa purification
This study was approved by the Institutional Ethics Committee of Saarland University (13/14). All participants gave written consent before participation in this study. All of the samples were analyzed in the laboratory of the Department of Molecular Biology, Genetics & Epigenetics at the University of Saarland. Samples were analyzed according to standard operating procedures. Briefly, semen samples were collected from proven fertile males (having at least two children) as a control group, and males who suffered from reduced fecundity (unable to have children after 5 years of unprotected sexual intercourse) as the case group. The exclusion criteria for participation in the study were as follows: diabetes mellitus, alcohol drinkers, the presence of anti-sperm antibodies, varicocoele, Y chromosome microdeletions, smokers, abnormal hormonal parameters, abnormal body mass index, and infertility related to the woman. In contrast, the inclusion criteria for the study population were the following: the participants included in this study have not a direct contact with environmental pollutants, males of same nationality, ethnicity, and food supplementation. Semen samples were collected by masturbation after 3 days of sexual abstinence, allowed to liquefy at 37°C for 30 min, sperm count was assessed using Meckler counting chamber (Sefi-Medica, Haifa, Israel). Thereafter, the semen was processed through gradient centrifugation. The sperm parameters were analyzed according to World Health Organization guidelines (WHO, 2010) . Before DNA extraction from spermatozoa, somatic cells have been removed from all the semen samples through the use of somatic cell lysis buffer (SCLB) which are used widely for sperm cell purification (Goodrich et al., 2007; Johnson et al., 2011; Sun et al., 2016) .
First, pure populations of spermatozoa were obtained through a 50% gradient (20 min at 300 g), then the pure spermatozoa were incubated with SCLB on ice for 30 min, and washed two times with phosphate-buffered saline (10 min at 500 g). The absence of somatic cells contamination has been confirmed by microscopic examination.
Sperm DNA isolation and sodium bisulfite treatment Sperm DNA was extracted using the Isolate II genomic DNA kit according to the standard protocol provided by the manufacturer (Cat. #: BIO 52066; Bioline, London, UK). The concentration and purity of extracted DNA were determined with the use of a Nanodrop spectrophotometer (ND-2000c; Thermo Scientific, Waltham, MA, USA). Five hundred nanograms of extracted sperm DNA was treated with sodium bisulfite using the Epitect bisulfite conversion kit (Cat. #: 59104; Qiagen, Venlo, Netherlands) that converts unmethylated cytosines to uracil, while 5-methylcytosine (5MeC) remains unaltered, as described previously (Wu et al., 2015) .
DNA methylation analysis by the Infinium 450K BeadChip array
Thirty semen samples were used as a screening study with a mean subject age of 38.0 years, range 23-45 years (15 samples from cases and 15 from controls). After the bisulfite treatment process, the DNA of these samples was subjected to the Infinium 450K BeadChip array (Illumina, San Diego, CA, USA) following the manufacturer's recommendations (Bibikova et al., 2011) , and the arrays were scanned using the Illumina iScan. Betavalues were then generated by analyzing the intensity of methylation or the absence of methylation at each CpG tile on the array using the calculation: b-value = methylated/ (methylated + unmethylated). The b-value ranges from 0 to 1 and indicates the methylation level for each CpG. A value of 1 represents a completely methylated CpG and a score of 0 means a completely unmethylated CpG. Raw intensity values obtained from Illumina were used to generate b-values; the bioinformatic processing and evaluation were performed with the RNBEADS program package (Assenov et al., 2014) . The methylation level at each CpG was considered as being differentially methylated CpG (DMC) when the absolute difference in the means of the average beta values between the two groups was ≥20% with a Benjamini-Hochberg corrected t-test FDR (false discovery rate) of 0.05. We excluded all CpG sites from the analysis with a coverage (number of beads) less than or equal to 5, and all CpG sites with a coverage (number of beads) of ≤5 were excluded from the analysis. Findings were considered significant when p ≤ 0.01. Referring to the technical results of hybridization, the gene call rate above 98% per sample and a detection value p < 0.01 per CpG site were set as internal quality criteria. All CpGs that covered a common SNP site in the dbSNP137 database were excluded. In this work and according to the 450K results, we assessed four CpG sites and validated them using 111 samples, not including the screening study samples, using gene-specific deep bisulfite sequencing (Bi-PROF; Gries et al., 2013) .
Bisulfite profiling
Five hundred nanograms of genomic DNA were bisulfite treated using the Epitect bisulfite conversion kit (Cat. #: 59104;
972 Andrology, 2017, 5, 971-978 Qiagen). PCRs encompassing the differentially methylated CpG (DMC) identified by the 450K BeadChip array were performed in a 50 lL total volume reaction using MyTaq TM HS Red Mix 2x concentrated (Cat. #: BIO-25047; Bioline) according to the manufacturer's protocol. For the amplification, fusion primers were used that consisted of a specific 3 0 portion (listed in Table 1, together with respective annealing temperatures and number of CpGs present within the amplicon sequence) and a universal 5 0 portion containing the necessary nucleotide sequences for Illumina sequencing. Primers were designed using the BiSearch primer design tool (http://bisearch.enzim.hu/?m=sea rch) using the following criteria: maximum length of PCR (400), primer concentration = 0.167 lM, potassium concentration = 50 mM, magnesium concentration = 2.5 mM, primer length 20-30, and maximum difference in melting temperature = 2.0°C. Using BiSearch, placing primers onto common SNPs could be eliminated. For this assay, 5 lL of each PCR reaction was loaded onto a 2% agarose gel stained with ethidium bromide (Cat. #: N0467S; New England Biolabs, Ipswich, MA, USA). The PCR products were purified using Agencourt â AMPure XP beads (Cat. #: A63880; Beckman Coulter, Berry, CA, USA) and measured using Quant-iT TM DNA Assay Kit (Cat. #: Q33120; Fisher Scientific, Hampton, NH, USA) according to the manufacturer's recommendations, then diluted and pooled. Deep sequencing was performed on the Illumina MiSeq according to the manufacturer's protocols aiming at 10,000 reads per amplicon. All data obtained from the deep sequencing step were processed, filtered, and aligned using BiQ Analyzer HT software (Lutsik et al., 2011) , excluding all reads containing equal or more than 10% of missing CpG sites (maximal fraction of unrecognized sites ≥0.1). The obtained alignment sequences showed an absence of alterations at CpG positions (no SNPs were detected).
Statistical analysis
Data obtained from Bi-PROF were analyzed using IBM SPSS for Windows software package version 24.0 (SPSS, Inc., Chicago, IL, USA). Samples included in this study were non-normally distributed (non-parametric) according to the value of skewness test, kurtosis test, Z-value, and Shapiro test. The independent sample t-test (Mann-Whitney test) was used to compare the means of quantitative variables, and Spearman's test was used to assess the correlation coefficient between methylation level in DMC and sperm parameters. The results in the above-mentioned procedures were accepted as statistically significant when p ≤ 0.05.
RESULTS
In this study, 30 sperm DNA samples (15 samples as cases and 15 samples as controls) were taken as a screening study and subjected to Infinium 450K BeadChip analysis, obtaining the DNA methylation levels of approximately 485,000 CpG positions in each sample. Table S1 summarizes the location of the most differentially methylated CpGs (DMC) based on the mean DNA methylation difference of ≥20% between the males with reduced fecundity (cases) and the proven fertile males (controls). Overall, we found only nine CpG positions meeting the criteria. Six out of nine differentially methylated regions (cg05799088, cg07227024, cg16338278, cg08408433, cg23081194, and cg19779893) are located in gene bodies and CpG islands, while three were found in intergenic regions (cg04807108, cg25750688, and cg19406113). From the results of this genome-wide study, we selected the following CpG sites to validate the observed methylation differences in 111 samples. 1 cg07227024: located in intron 2 of the ALS2CR12 gene, within a DNase I hypersensitivity cluster and a region slightly enriched for H3K4me1 (ENCODE, 2012). 2 cg16338278: located in exon 7 of the ALDH3B2 gene, within a strong DNase I hypersensitivity cluster and the transcription factor binding site motif CTCF (ENCODE, 2012). 3 cg05799088: located in exon 8 of the PRICKLE2 gene, located within the transcription factor binding sites of (i) FOSL2, which plays a critical role in the regulation of cell proliferation, differentiation, and transformation, (ii) MAX, which may repress transcription via the recruitment of a chromatin remodeling complex with H3K9 histone methyltransferase activity, and (iii) POU5F1, which plays a role in early embryogenesis and is necessary for embryonic stem cell pluripotency. All of them supposed to be binding sites (ENCODE, 2012) . Similarly, the CpG is located within a DNase I cluster and in a region slightly enriched for H3K4me1. 4 cg08408433: located in exon 2 of the PTGIR gene, neighboring a DNase I hypersensitivity cluster and a region slightly enriched for H3K4me1 (ENCODE, 2012). Table 2 illustrates the descriptive characteristics of the study population. The age of the males included in the study population was between 24.0 and 45.0 years, with mean age of 34.93 AE 5.84 years. The study population was divided into two groups: the control group was composed of 56 males with a mean age of 33.98 AE 5.53 years, and the case group was composed of 55 males with reduced fecundity and who had been unable to have children after 5 years of attempting pregnancy with mean age 35.89 AE 6.03 years. The semen parameters showed highly significant differences in semen volume (p ≤ 0.001), sperm count (p ≤ 0.0001), the percentage of total sperm motility (p ≤ 0.0001), the percentage of sperm with progressive motility (p ≤ 0.0001), the percentage of spermatozoa with non-progressive motility (p ≤ 0.0001), and the sperm vitality (p ≤ 0.0001) between the case and control groups. Moreover, a statistically significant difference between cases and controls in the percentage of spermatozoa with a normal form (p ≤ 0.027) was observed (Table 2 ). According to the results of local deep bisulfite sequencing, the study revealed that not only the target CpGs obtained from the 450K bead array experiments showed a difference in the methylation level, but also neighboring CpGs. A significant difference in the mean methylation level was found between cases and controls in all CpGs of the PRICKLE2 gene-related amplicon (CpG1, p ≤ 0.002, and CpG2, p ≤ 0.004) (Fig. 1 ) and the ALS2CR12 gene-related amplicon (CpG1, p ≤ 0.015, and CpG2, p ≤ 0.009) (Fig. 2) . Besides, a significant difference was found at seven of thirteen CpGs tested in the ALDH3B2 gene-related amplicon CpG2, CpG6, CpG9, CpG10, CpG11, CpG12, and CpG13 (p ≤ 0.005, p ≤ 0.004, p ≤ 0.012, p ≤ 0.028, p ≤ 0.012, p ≤ 0.009, and p ≤ 0.001, respectively) (Fig. 3) . In addition, the results showed that nine CpGs out of the twenty-six within the PTGIR gene-related amplicon (CpG4, CpG6, CpG8, CpG9, CpG11, CpG15, CpG19, CpG23, and CpG26) showed a significant difference in their mean methylation level (p ≤ 0.006, p ≤ 0.009, p ≤ 0.003, p ≤ 0.003, p ≤ 0.007, p ≤ 0.002, p ≤ 0.018, p ≤ 0.018, and p ≤ 0.040, respectively) in the case vs. the control group (Fig. 4) . Finally, the study assessed the correlation between the methylation levels obtained by Bi-PROF at different CpGs (DMC) and other semen parameters of the cases (Table S2) . A positive significant correlation was found between the mean methylation levels in (CpG2, CpG3, CpG10, CpG11, CpG12, and CpG13) of the ALDH3B2 gene-related amplicon and sperm count (p ≤ 0.046, p ≤ 0.001, p ≤ 0.002, p ≤ 0.004, p ≤ 0.004, and p ≤ 0.012, respectively). Additionally, a positive significant correlation was found between the methylation level of CpG2 and the percentage of spermatozoa with non-progressive motility (p ≤ 0.032) and the percentage of immobile spermatozoa (p ≤ 0.024) for the same gene amplicon. On the other hand, a significant positive correlation was observed between the mean methylation levels of CpG10, CpG13, CpG14, CpG16, and CpG22 within the PTGIR gene-related amplicon, and the percentage of immobile sperm (p ≤ 0.029, p ≤ 0.008, p ≤ 0.023, p ≤ 0.026, and p ≤ 0.032, respectively). Furthermore, a significant negative correlation was shown between the mean methylation level of a number of CpGs (CpG1, CpG2, CpG6, CpG9, CpG10, CpG12, CpG13, CpG14, CpG16, CpG18, CpG21, CpG22, CpG24, and CpG25) obtained by Bi-PROF for the PTGIR gene-related amplicon and the sperm vitality (p ≤ 0.017, p ≤ 0.050, p ≤ 0.040, p ≤ 0.029, p ≤ 0.005, p ≤ 0.050, p ≤ 0.013, p ≤ 0.016, p ≤ 0.017, p ≤ 0.024, p ≤ 0.037, p ≤ 0.016, p ≤ 0.029, and p ≤ 0.016, respectively). 974 Andrology, 2017, 5, 971-978
DISCUSSION
The present study evaluated the association between changes in sperm DNA methylation levels and semen parameters, which were obtained from males with reduced fecundity and proven fertile males. The results obtained from local deep sequencing showed a significant decrease in the methylation level between the case and control groups in all CpGs for the PRICKLE2 amplicon (CpG1, p ≤ 0.002; CpG2, p ≤ 0.004) and ALS2CR12 gene (CpG1, p ≤ 0.015; CpG2, p ≤ 0.009). Additionally, a significant decrease in methylation at CpG2, CpG6, CpG9, CpG10, CpG11, CpG12, and CpG13 for the ALDH3B2 amplicon, and at CpG4, CpG6, CpG8, CpG9, CpG11, CpG15, CpG19, CpG23, and CpG26 for the PTGIR amplicon was found in the case group compared to the control group (Fig. 1) . DNA methylation plays a critical role in the spermatogenesis process (Carrell, 2012; Bao & Bedford, 2016) , and several previous studies have reported that one of the most common reasons that lead to a reduction in male reproductive potential and defects in spermatogenesis may be related to abnormal methylation at specific genes that are expressed in the testes (Krausz et al., 2012; Gr egoire et al., 2013; Niederberger, 2013; Jenkins et al., 2016b) . Also, different studies have found a strong relationship between a change in the level of DNA methylation in spermatozoa and infertility in males (Hammoud et al., 2010; Poplinski et al., 2010; Sato et al., 2011; Ramasamy et al., 2014; Urdinguio et al., 2015) . The results obtained from the study of Aston et al. showed that some CpGs in the sperm genome of patients who suffered from a reduction in fecundity and underwent assisted reproductive technologies had alterations in the DNA methylation pattern. They proposed performing a genome-wide evaluation of sperm DNA methylation and hypothesized that DNA methylation may help to predict male fertility status as well as embryo quality (Aston et al., 2015) . Overall, our results are consistent with studies that have reported a change in DNA methylation in normal spermatozoa compared to poor spermatozoa Montjean et al., 2013) . Other studies reported that males suffering from a reduction in fecundity have a low level of sperm DNA methylation compared with control males (Aoki et al., 2006; Boissonnas et al., 2010; Ferfouri et al., 2013) . However, the results of this study contradict other studies (Houshdaran et al., 2007; Jenkins et al., 2016b) because no association was observed between changes in global sperm DNA methylation profiles and reduced semen parameters or poor sperm quality. It is worth mentioning that all analyzed genes, that is, ALS2CR12, ALDH3B, PRICKLE2, and PTGIR play a critical role in the process of spermatogenesis and sperm capacity (Curry et al., 2009; Fuchs et al., 2010; Choi & Cho, 2011; Matzkin et al., 2012; Gong et al., 2013) . ALS2CR12 transcripts are present in different stages of sperm development and associated with the fibrous sheath in the sperm flagellum (Choi & Cho, 2011) . The fibrous sheath has been shown to be important for mechanical flagellar function (Chemes, 2000; Rawe et al., 2001) and plays a crucial role in regulating key processes leading up to fertilization (Eddy et al., 2003) . ALDH3B2 plays unique roles in the cellular defense against oxidative stress and aldehyde toxicity (Marchitti et al., 2010) , and the protein family ALDH3B2 has been implicated in the etiology of some human pathologies such as cancer and male infertility (Shiraishi & Naito, 2007; Fuchs et al., 2010) . PRICKLE2 is part of the non-canonical Wnt signaling pathway, which is involved in the planar cell polarity (PCP) pathway, a major signaling pathway during testis development (Bassuk et al., 2008; Kerr et al., 2014) . Based on previous studies, it is very probable that Wnt signaling functions appear in late spermatogenesis and mainly regulates morphological changes in spermatids (Ma et al., 2006; Nicol & Guiguen, 2011) . The expression of PTGIR has been found in Sertoli cells, and this prostaglandin and its receptors are required for fertility and reproduction (Ishikawa & Morris, 2006; Matzkin et al., 2012) . Further studies on larger sample cohorts will show if the identified CpGs are responsible and potential predictors for transcriptional abnormalities in spermatozoa obtained from males suffering from infertility or reduced fecundity. According to the values of semen parameters between the case and control groups, the results show a strongly significant difference in semen volume, sperm count, the percentage of spermatozoa with full motility, the percentage of spermatozoa with progressive motility, sperm vitality, and the percentage of spermatozoa with a normal form (p ≤ 0.001, p ≤ 0.0001, p ≤ 0.0001, p ≤ 0.0001, p ≤ 0.0001, and p ≤ 0.027, respectively). This is consistent with previous studies (Poplinski et al., 2010; Nanassy & Carrell, 2011; T€ urk et al., 2014) .
Finally, this study showed a positive correlation between methylation levels in some DMCs related to the ALDH3B2 and PTGIR gene amplicons, and some semen parameters like sperm count, the percentage of non-progressive spermatozoa, and the percentage of immobile spermatozoa (Table S2 ). This agrees with a previous study showing a positive correlation between the sperm DNA methylation level, sperm count, and sperm motility (Montjean et al., 2015) . In the end, all the results of this study indicate the presence of a strong association between changes in sperm DNA methylation levels and fecundity decline in males. Together with other studies, it also indicates that epigenetics might influence the quality and quantity of spermatogenesis (Minor et al., 2011; Kl€ aver & Gromoll, 2014) .
CONCLUSION
This study identified different CpGs related to ALS2CR12, ALDH3B2, PRICKLE2, and PTGIR with consistently altered methylation levels in sperm DNA from males with reduced fecundity. In addition, an association between changes in the methylation level for these CpGs and different semen parameters was found. The observed variations may have an influence on sperm phenotype. More studies are needed to clarify the mechanisms relating to these alterations and to discover their significance and functional consequences for male fecundity.
